Their data indicated that the HMGB1/RAGE/NF-κB signaling might play an important role in skin inflammation, and quercetin treatment could be a promising agent for AD by modulating the HMGB1/RAGE/NF-κB signaling and induction of Nrf2 protein [55] (Table 2). Here, HMGB1 is linked to Alzheimer disease.